RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  McCulloch, Michael ^a   Alvarez, Esperanza ^b   Gendreau, Rob ^b   Haney, Stephanie ^b   Harrelson, Joshua ^a   Luo, Rona ^a  

^a Pine Street Foundation ^*  (United States)

^b American College of Traditional Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

BLOOD; HUMAN; MALE; NOTE; PROSTATE TUMOR;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84898860962     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju024     Document Type: Letter

References (7)

1. Brasky TM, Darke AK, Song X, et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013;105(15):1132-1141.
2. Schlierf G, Wood P. Quantitative determination of plasma free fatty acids and triglycer-ides by thin-layer chromatography. J Lipid Res. 1965; 6:317-319.
3. Torfadottir JE, Valdimarsdottir UA, Mucci LA, et al. Consumption of fish products across the lifespan and prostate cancer risk. PLoS One. 2013;8(4):e59799.
4. Reese AC, Fradet V, Witte JS: omega-3 fatty acids, genetic variants in CoX-2 and prostate cancer. J Nutrigenet Nutrigenomics. 2009;2(3):149-158.
5. Crowe FL, Allen NE, Appleby PN, et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective investigation into Cancer and nutrition. Am J Clin Nutr. 2008;88(5):1353-1363.
6. Ornish D, Magbanua MJ, Weidner G, et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA. 2008;105(24):8369-8374.
7. Chow CK. Fatty acid composition of plasma phospholipids and risk of prostate cancer. Am J Clin Nutr. 2009;89(6):1946; author reply 1946-1947.